Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1370684
European Journal of Endocrinology, Vol 137, Issue 6, 684-687
Copyright © 1997 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mayr, B
Right arrow Articles by Brabant, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mayr, B
Right arrow Articles by Brabant, G

Articles

Menin mutations in patients with multiple endocrine neoplasia type 1

B Mayr, S Apenberg, T Rothamel, A von zur Muhlen, and G Brabant

Abteilung Klinische Endokrinologie, Medizinische Hochschule Hannover, Germany.

Multiple endocrine neoplasia type 1 (MEN-1) is a familial cancer syndrome with parathyroid, pituitary and enteropancreatic tumors. The disease phenotype segregates with markers on chromosome 11q13. Very recently a new gene was cloned from this region and was found to carry mutations in 14 of 15 unrelated MEN-1 patients. The gene was termed menin and is predicted to code for a tumor suppressor protein of 610 amino acids, but its precise function is totally unknown. To confirm this finding we used PCR from genomic DNA and direct sequencing to analyze exons 2 through 10 of the menin gene in eight patients from four pedigrees with MEN-1 syndrome or an affected relative. We identified four different heterozygous mutations, three of them are novel: one nonsense mutation, one large deletion of 32 bp and two insertions, all of them located in exon 2. Our results confirm that patients with MEN-1 carry mutations in the menin gene.


This article has been cited by other articles:


Home page
Mol Cancer ResHome page
L. E. MacConaill, C. M. Hughes, O. Rozenblatt-Rosen, S. Nannepaga, and M. Meyerson
Phosphorylation of the Menin Tumor Suppressor Protein on Serine 543 and Serine 583
Mol. Cancer Res., October 1, 2006; 4(10): 793 - 801.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. S. Guo and M. P. Sawicki
Molecular and Genetic Mechanisms of Tumorigenesis in Multiple Endocrine Neoplasia Type-1
Mol. Endocrinol., October 1, 2001; 15(10): 1653 - 1664.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. M. R. Bhuiyan, M. Sato, K. Murao, H. Imachi, H. Namihira, and J. Takahara
Expression of Menin in Parathyroid Tumors
J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2615 - 2619.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Mayr, G. Brabant, and A. v. z. Mühlen
Menin Mutations In MEN1 Patients
J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 3004 - 3005.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 European Society of Endocrinology.